Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -581,632 | -540,695 | -516,755 | -703,488 | -594,244 |
| Depreciation Amortization | 178 | 1,852 | 2,654 | 31,213 | 26,793 |
| Accounts receivable | -104,227 | -22,180 | -9,208 | -61,638 | -48,519 |
| Other Working Capital | -330,799 | -176,087 | -121,577 | -39,470 | 11,923 |
| Other Operating Activity | 570,144 | 405,480 | 435,490 | 448,037 | 371,093 |
| Operating Cash Flow | $-446,336 | $-331,630 | $-209,396 | $-325,346 | $-232,954 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -135,139 | 34,659 | 22,071 | N/A | -1,032,594 |
| PPE Investments | -57,067 | -27,394 | -9,485 | -30,824 | -22,860 |
| Purchase Of Investment | N/A | N/A | N/A | -1,937,856 | N/A |
| Sale Of Investment | N/A | N/A | N/A | 923,224 | N/A |
| Purchase Sale Intangibles | 90,761 | 101,861 | -94 | -1,427 | -1,225 |
| Other Investing Activity | 90,761 | 101,861 | -94 | -1,427 | -1,225 |
| Investing Cash Flow | $-101,445 | $109,126 | $12,492 | $-1,046,883 | $-1,056,679 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 1,127,400 | 1,127,400 |
| Debt Repayment | N/A | N/A | N/A | -823,232 | -823,232 |
| Common Stock Issued | 49,303 | 33,898 | 28,037 | 30,043 | 18,740 |
| Other Financing Activity | 73,758 | 73,758 | 73,758 | -101,704 | -101,150 |
| Financing Cash Flow | $123,061 | $107,656 | $101,795 | $232,507 | $221,758 |
| Beginning Cash Position | 985,801 | 985,801 | 985,801 | 2,125,523 | 2,125,523 |
| End Cash Position | 561,081 | 870,953 | 890,692 | 985,801 | 1,057,648 |
| Net Cash Flow | $-424,720 | $-114,848 | $-95,109 | $-1,139,722 | $-1,067,875 |
| Free Cash Flow | |||||
| Operating Cash Flow | -446,336 | -331,630 | -209,396 | -325,346 | -232,954 |
| Capital Expenditure | -57,067 | -27,394 | -9,485 | -30,824 | -22,860 |
| Free Cash Flow | -503,403 | -359,024 | -218,881 | -356,170 | -255,814 |